Loading
COMPASS Pathways plc Stock: price and insider trades · United States
Insider Decl.
141
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€24M
73 ops. · all time
Analyst consensus: bullish or bearish?
Analysts rate COMPASS Pathways plc Strong Buy (bullish), based on 16 analysts. Average price target: US$23.75.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$11.90
Analyst consensus
16 analystsStrong buy
US$13.00Target US$23.75(+100%)US$65.00
Income statement
EBITDA-US$285.6M
Net income-US$287.9M0.0% margin
Valuation
PER (forward)-8.3x
P/Book19.1x
Beta2.56
Balance sheet & cash
Market capUS$1.6B
Total debtUS$35M
Free Cash Flow-US$157.2M
Debt / Equity65%
Profitability & ownership
ROE-319.1%
ROA-29.1%
% insiders7.6%
% institutions68.7%
Last declaration on 10 August 2026
Declarations141 total
26,000 shares@ US$13.300.019% mcap22.3% of flowAmerican Depositary SharesSEC144:0001959173-26-005811
83,771 shares@ US$13.71780.063% mcap74.3% of flowAmerican Depositary SharesSEC144:0001959173-26-005736
5,962 shares@ US$11.250.0037% mcap13.0% of flowOrdinary SharesSEC:0001940258-26-000011:0
175,000 shares0Ordinary SharesSEC:0001940258-26-000009:0
75,000 shares0Ordinary SharesSEC:0001829111-26-000007:0
13,131 shares@ US$6.8917.4% of flowOrdinary SharesSEC:0001940258-26-000006:0
1,781 shares@ US$6.8919.9% of flowOrdinary SharesSEC:0001829111-26-000004:0
4,467 shares@ US$7.0250.3% of flowOrdinary SharesSEC:0001829111-26-000002:0
16,181 shares@ US$6.6120.1% of flowOrdinary SharesSEC:0001940258-26-000004:0
6,366 shares@ US$4.345.4% of flowOrdinary SharesSEC:0001816590-25-000106:0
25,000 shares0Ordinary SharesSEC:0001816590-25-000025:0
92,000 shares0Ordinary SharesSEC:0001816590-25-000024:0
4,468 shares@ US$3.6729.7% of flowOrdinary SharesSEC:0001816590-25-000020:0
15,516 shares@ US$4.3114.5% of flowOrdinary SharesSEC:0001816590-25-000010:0
776,565 sharesOrdinary SharesSEC:0001816590-24-000125:1
776,565 sharesOrdinary SharesSEC:0001816590-24-000126:1
776,565 sharesOrdinary SharesSEC:0001816590-24-000125:0
776,565 sharesOrdinary SharesSEC:0001816590-24-000126:0
2,660,000 shares@ US$6.05100.0% of flowOrdinary SharesSEC:0001140361-24-042246:0
7,064 shares@ US$6.8810.0% of flowOrdinary SharesSEC:0001628280-24-034537:0
161 shares@ US$6.880.1% of flowOrdinary SharesSEC:0001628280-24-034539:0
6,703 shares@ US$7.891.0% of flowOrdinary SharesSEC:0001816590-24-000104:1
6,704 shares@ US$7.891.0% of flowOrdinary SharesSEC:0001816590-24-000103:1
8,900 shares@ US$7.911.3% of flowOrdinary SharesSEC:0001816590-24-000103:2
8,900 shares@ US$7.911.3% of flowOrdinary SharesSEC:0001816590-24-000104:2
25 of 141 declarations
About COMPASS Pathways plc
No purchase appears among the 141 filings of COMPASS Pathways plc (Health Care), which involve 11 filers. The record is made of 73 sales, 69 of them with a known amount totaling EUR 23,727,317 (median EUR 154,170), 66 grants and 2 filings of another kind.
The largest sale is by ATAI Life Sciences N.V.: EUR 14,398,086 on September 26, 2024. On February 7, 2024, directors George Jay Goldsmith and Ekaterina Malievskaia each sold EUR 223,761. Both are also filed as holders of more than 10%; each has 51 filings, of which 35 sales. Kabir Nath (Chief Executive Officer) has 14, Annalisa Jenkins 7 and Teri Loxam (Chief Financial Officer) 6.
Read moreShow less
Activity is concentrated: 79 filings in 2024 and 37 in 2023, against 5 in 2025. The last twelve months hold only 9, with no purchase and no sale. Publication follows the trade by a median of 2 days. Insiders hold 7.6% of the capital, valued at USD 1.6 billion.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
